At the 2026 Unbreakable Health Retreat in Miami, Emily Kaplan hosted a panel with Bob Kaplan, Professor Thomas Seyfried, and Dr. Derek Lee on what it means to treat cancer as a metabolic disease. They discussed the glucose-ketone index (GKI), nutritional ketosis, and strategies aimed at restricting the fuels cancer cells depend on while considering how metabolic therapy can fit alongside standard cancer treatment.
The conversation also addressed the practical realities patients face when trying to pursue a metabolic approach within the conventional oncology system, including questions about nutrition, repurposed drugs, inherited cancer risk, and how to evaluate different treatment options. Seyfried and Lee connected these clinical questions back to mitochondrial dysfunction, fermentation, and the metabolic vulnerabilities that may offer additional targets for cancer treatment.
An abbreviated version of this discussion is available here, for free.
MetFix and BSI Members can view the full 41-minute video here (members only).
Let's start with the truth!
Support the Broken Science Initiative.
Subscribe today →
recent posts
GKI, ketogenic therapy, standard care, and treating cancer metabolically
Cancer as a metabolic disease—and the case against the somatic mutation theory
Metabolic health, medical education, and the case for bringing clinicians and coaches together
